Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations

Leiomyomas are smooth muscle-derived benign neoplasms that can affect all organs, most frequently in the uterus. Fumarate hydratase gene (FH) mutation is characterised by an autosomal dominant disease with increased occurrence of renal tumours, but also by cutaneous (CLs) and uterine leiomyomas (ULs...

Full description

Bibliographic Details
Main Authors: Elena Campione, Monia Di Prete, Gaetana Costanza, Andrea Saggini, Sara Agostinelli, Alessandro Terrinoni, Federica Centofanti, Maria Cristina Rapanotti, Luca Bianchi, Amedeo Ferlosio, Maria Giovanna Scioli, Augusto Orlandi
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Dermatopathology
Subjects:
Online Access:https://www.mdpi.com/2296-3529/10/3/32
_version_ 1797580601610469376
author Elena Campione
Monia Di Prete
Gaetana Costanza
Andrea Saggini
Sara Agostinelli
Alessandro Terrinoni
Federica Centofanti
Maria Cristina Rapanotti
Luca Bianchi
Amedeo Ferlosio
Maria Giovanna Scioli
Augusto Orlandi
author_facet Elena Campione
Monia Di Prete
Gaetana Costanza
Andrea Saggini
Sara Agostinelli
Alessandro Terrinoni
Federica Centofanti
Maria Cristina Rapanotti
Luca Bianchi
Amedeo Ferlosio
Maria Giovanna Scioli
Augusto Orlandi
author_sort Elena Campione
collection DOAJ
description Leiomyomas are smooth muscle-derived benign neoplasms that can affect all organs, most frequently in the uterus. Fumarate hydratase gene (FH) mutation is characterised by an autosomal dominant disease with increased occurrence of renal tumours, but also by cutaneous (CLs) and uterine leiomyomas (ULs). So far, an increased occurrence of skin tumours in non-mutated patients with ULs has not been verified. To this aim, a case-group of women who were FH non-mutated patients surgically treated for ULs (<i>n</i> = 34) was compared with a control-group (<i>n</i> = 37) of consecutive age-matched healthy women. The occurrence of skin neoplasms, including CLs and dermatofibromas (DFs), was evaluated. Moreover, the microscopic features of FH non-mutated skin tumours were compared with those of an age-matched population group (<i>n</i> = 70) who presented, in their clinical history, only one type of skin tumour and no ULs. Immunohistochemical and in vitro studies analysed TGFβ and vitamin D receptor expression. FH non-mutated patients with ULs displayed a higher occurrence of CLs and DFs (<i>p</i> < 0.03 and <i>p</i> < 0.001), but not of other types of skin tumours. Immunohistochemistry revealed a lower vitamin D receptor (VDR) expression in CLs and DFs from the ULs group compared with those from the population group (<i>p</i> < 0.01), but a similar distribution of TGFβ-receptors and SMAD3. In vitro studies documented that TGFβ-1 treatment and vitamin D3 have opposite effects on α-SMA, TGFβR2 and VDR expression on dermal fibroblast and leiomyoma cell cultures. This unreported increased occurrence of CLs and DFs in FH non-mutated patients with symptomatic ULs with vitamin D deficiency suggests a potential pathogenetic role of vitamin D bioavailability also for CLs and DFs.
first_indexed 2024-03-10T22:53:10Z
format Article
id doaj.art-569b86fad96e4f009490147af1061449
institution Directory Open Access Journal
issn 2296-3529
language English
last_indexed 2024-03-10T22:53:10Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Dermatopathology
spelling doaj.art-569b86fad96e4f009490147af10614492023-11-19T10:12:21ZengMDPI AGDermatopathology2296-35292023-08-0110323124310.3390/dermatopathology10030032Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene MutationsElena Campione0Monia Di Prete1Gaetana Costanza2Andrea Saggini3Sara Agostinelli4Alessandro Terrinoni5Federica Centofanti6Maria Cristina Rapanotti7Luca Bianchi8Amedeo Ferlosio9Maria Giovanna Scioli10Augusto Orlandi11Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyDepartment of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyDermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyInstitute of Anatomic Pathology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, ItalyLeiomyomas are smooth muscle-derived benign neoplasms that can affect all organs, most frequently in the uterus. Fumarate hydratase gene (FH) mutation is characterised by an autosomal dominant disease with increased occurrence of renal tumours, but also by cutaneous (CLs) and uterine leiomyomas (ULs). So far, an increased occurrence of skin tumours in non-mutated patients with ULs has not been verified. To this aim, a case-group of women who were FH non-mutated patients surgically treated for ULs (<i>n</i> = 34) was compared with a control-group (<i>n</i> = 37) of consecutive age-matched healthy women. The occurrence of skin neoplasms, including CLs and dermatofibromas (DFs), was evaluated. Moreover, the microscopic features of FH non-mutated skin tumours were compared with those of an age-matched population group (<i>n</i> = 70) who presented, in their clinical history, only one type of skin tumour and no ULs. Immunohistochemical and in vitro studies analysed TGFβ and vitamin D receptor expression. FH non-mutated patients with ULs displayed a higher occurrence of CLs and DFs (<i>p</i> < 0.03 and <i>p</i> < 0.001), but not of other types of skin tumours. Immunohistochemistry revealed a lower vitamin D receptor (VDR) expression in CLs and DFs from the ULs group compared with those from the population group (<i>p</i> < 0.01), but a similar distribution of TGFβ-receptors and SMAD3. In vitro studies documented that TGFβ-1 treatment and vitamin D3 have opposite effects on α-SMA, TGFβR2 and VDR expression on dermal fibroblast and leiomyoma cell cultures. This unreported increased occurrence of CLs and DFs in FH non-mutated patients with symptomatic ULs with vitamin D deficiency suggests a potential pathogenetic role of vitamin D bioavailability also for CLs and DFs.https://www.mdpi.com/2296-3529/10/3/32cutaneous leiomyomadermatofibromauterine leiomyomavitamin DTGFβ-1
spellingShingle Elena Campione
Monia Di Prete
Gaetana Costanza
Andrea Saggini
Sara Agostinelli
Alessandro Terrinoni
Federica Centofanti
Maria Cristina Rapanotti
Luca Bianchi
Amedeo Ferlosio
Maria Giovanna Scioli
Augusto Orlandi
Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
Dermatopathology
cutaneous leiomyoma
dermatofibroma
uterine leiomyoma
vitamin D
TGFβ-1
title Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
title_full Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
title_fullStr Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
title_full_unstemmed Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
title_short Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
title_sort increased occurrence of cutaneous leiomyomas and dermatofibromas in patients with uterine leiomyomas without fumarate hydratase gene mutations
topic cutaneous leiomyoma
dermatofibroma
uterine leiomyoma
vitamin D
TGFβ-1
url https://www.mdpi.com/2296-3529/10/3/32
work_keys_str_mv AT elenacampione increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT moniadiprete increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT gaetanacostanza increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT andreasaggini increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT saraagostinelli increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT alessandroterrinoni increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT federicacentofanti increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT mariacristinarapanotti increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT lucabianchi increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT amedeoferlosio increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT mariagiovannascioli increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations
AT augustoorlandi increasedoccurrenceofcutaneousleiomyomasanddermatofibromasinpatientswithuterineleiomyomaswithoutfumaratehydratasegenemutations